Literature DB >> 11747320

Activation and activities of the p53 tumour suppressor protein.

E Bálint E1, K H Vousden.   

Abstract

The p53 tumour suppressor protein inhibits malignant progression by mediating cell cycle arrest, apoptosis or repair following cellular stress. One of the major regulators of p53 function is the MDM2 protein, and multiple forms of cellular stress activate p53 by inhibiting the MDM2-mediated degradation of p53. Mutations in p53, or disruption of the pathways that allow activation of p53, seem to be a general feature of all cancers. Here we review recent advances in our understanding of the pathways that regulate p53 and the pathways that are induced by p53, as well as their implications for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747320      PMCID: PMC2364002          DOI: 10.1054/bjoc.2001.2128

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  212 in total

1.  The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal.

Authors:  M Prisco; A Hongo; M G Rizzo; A Sacchi; R Baserga
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

2.  MDMX: a novel p53-binding protein with some functional properties of MDM2.

Authors:  A Shvarts; W T Steegenga; N Riteco; T van Laar; P Dekker; M Bazuine; R C van Ham; W van der Houven van Oordt; G Hateboer; A J van der Eb; A G Jochemsen
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

3.  Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability.

Authors:  M H Kubbutat; K H Vousden
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

4.  Identification of redox/repair protein Ref-1 as a potent activator of p53.

Authors:  L Jayaraman; K G Murthy; C Zhu; T Curran; S Xanthoudakis; C Prives
Journal:  Genes Dev       Date:  1997-03-01       Impact factor: 11.361

5.  Inhibition of the growth of WI-38 fibroblasts by benzyloxycarbonyl-Leu-Leu-Tyr diazomethyl ketone: evidence that cleavage of p53 by a calpain-like protease is necessary for G1 to S-phase transition.

Authors:  W Zhang; Q Lu; Z J Xie; R L Mellgren
Journal:  Oncogene       Date:  1997-01-23       Impact factor: 9.867

6.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

7.  Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes.

Authors:  M Lohrum; K H Scheidtmann
Journal:  Oncogene       Date:  1996-12-19       Impact factor: 9.867

8.  Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

Authors:  N Rampino; H Yamamoto; Y Ionov; Y Li; H Sawai; J C Reed; M Perucho
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

9.  Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.

Authors:  K Lundgren; R Montes de Oca Luna; Y B McNeill; E P Emerick; B Spencer; C R Barfield; G Lozano; M P Rosenberg; C A Finlay
Journal:  Genes Dev       Date:  1997-03-15       Impact factor: 11.361

10.  p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.

Authors:  X Chen; L J Ko; L Jayaraman; C Prives
Journal:  Genes Dev       Date:  1996-10-01       Impact factor: 11.361

View more
  76 in total

1.  Involvement of the DNA repair protein hHR23 in p53 degradation.

Authors:  Sandra Glockzin; Francois-Xavier Ogi; Arnd Hengstermann; Martin Scheffner; Christine Blattner
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

2.  Involvement of Rho family GTPases in p19Arf- and p53-mediated proliferation of primary mouse embryonic fibroblasts.

Authors:  Fukun Guo; Yi Zheng
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

3.  Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase.

Authors:  Chun-Jen Chen; Kazuo Sugiyama; Hideyuki Kubo; Cheng Huang; Shinji Makino
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 4.  Understanding protein non-folding.

Authors:  Vladimir N Uversky; A Keith Dunker
Journal:  Biochim Biophys Acta       Date:  2010-02-01

5.  The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor.

Authors:  Gaynor J Bates; Samantha M Nicol; Brian J Wilson; Anne-Marie F Jacobs; Jean-Christophe Bourdon; Julie Wardrop; David J Gregory; David P Lane; Neil D Perkins; Frances V Fuller-Pace
Journal:  EMBO J       Date:  2005-01-20       Impact factor: 11.598

6.  Overexpressed heat shock protein 70 protects cells against DNA damage caused by ultraviolet C in a dose-dependent manner.

Authors:  Piye Niu; Lin Liu; Zhiyong Gong; Hao Tan; Feng Wang; Jing Yuan; Youmei Feng; Qingyi Wei; Robert M Tanguay; Tangchun Wu
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

7.  Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions.

Authors:  Hongbo Xie; Slobodan Vucetic; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Vladimir N Uversky; Zoran Obradovic
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

8.  Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins.

Authors:  Jinwoo Ahn; In-Ja L Byeon; Chang-Hyeock Byeon; Angela M Gronenborn
Journal:  J Biol Chem       Date:  2009-02-26       Impact factor: 5.157

Review 9.  Molecular staging of gynecological cancer: What is the future?

Authors:  Pratibha S Binder; Jaime Prat; David G Mutch
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2015-03-04       Impact factor: 5.237

10.  p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene.

Authors:  Shanthi Adimoolam; James M Ford
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.